Temperature control
All peptide pen orders are securely packed in thermally insulated packaging to help reduce temperature fluctuations during transport. Our MSSPT formulation approach is designed to support peptide stability during transport and storage. After delivery, follow the storage conditions stated for your pen.
MSSPT technology
MSSPT is ADRIA’s formulation approach for liquid peptide research materials. It brings together buffer and stabilizer selection with attention to light, oxidation, transport and storage conditions.
Performance depends on the specific compound, formulation and cartridge. Product-specific stability duration is not established by general ingredient studies.
Weight Loss Research · Peptide Pens
GLP-2 (Tirzepatide) Pen
In stock
Order within — to ship today
Arrives 26 – 30 Nov. to Europe
GLP-2 (Tirzepatide) Pen
153,00 € – 289,00 €Price range: 153,00 € through 289,00 €
The Adria GLP-2 or Tirzepatide (LY3298176, marketed as Mounjaro) Pen offers a simple, convenient, and precise way to work with Tirzepatide in research settings. As a dual GLP-1/GIP agonist, Tirzepatide is one of the most promising compounds for studies involving glucose regulation, appetite signaling, and weight management.
Compound information
Specifications
Molecular profile
- Sequence
- Y-Aib-EGTFTSDYSI-Aib-LDKIAQ-K(AEEA-AEEA-gamma-Glu-C20 diacid)-AFVQWLIAGGPSSGAPPPS-NH2
- Molecular mass
- 4813.45 g/mol
- CAS number
- 2023788-19-2
- Molecular formula
- C225H348N48O68
Material record
- Physical appearance
- Pre-mixed solution in a cartridge (planned pen format).
- Solubility
- Pre-reconstituted format; no reconstitution required.
- Product note
- Dual GIPR/GLP-1R pathway research compound; supplied strictly for research use only.
Research overview
GLP-2 (Tirzepatide) Pen
Why this pen is perfect for research:
- No preparation required
- Fully pre-formulated and ready. No mixing, no vials, no risk of mistakes.
- Extremely easy to handle
- Simply turn the dial to set your amount. Ideal for researchers with no prior experience using traditional peptides.
- Clean and safe workflow
- The closed pen system keeps everything hygienic and sterile and eliminates spills or contamination.
- Precise and consistent dosing
- The built-in scale ensures accurate measurements
- Reliable, stable quality
- Every application delivers the same concentration, supporting reproducible research results.
What is Tirzepatide?
Tirzepatide is a dual incretin receptor agonist that simultaneously activates the GLP-1 (Glucagon-Like Peptide-1)and GIP (Glucose-Dependent Insulinotropic Polypeptide) receptors.
This dual mechanism makes it a next-generation peptide in metabolic and weight regulation research, combining the glucose-lowering effects of GLP-1 agonists with the metabolic advantages of GIP stimulation.
By activating both signaling pathways, Tirzepatide has shown strong potential in preclinical and clinical studies for improving insulin sensitivity, reducing body fat, and optimizing energy metabolism.
Ideal for metabolic health, insulin regulation, and obesity mechanism research.
Key Research Findings
- Dual Receptor Activation: Stimulates both GLP-1 and GIP receptors for synergistic metabolic enhancement.
- Glucose Regulation: Promotes insulin secretion and improves glucose homeostasis.
- Fat Reduction: Leads to body fat reduction while maintaining lean body mass.
- Appetite Control: Regulates central mechanisms controlling hunger and satiety.
- Energy Metabolism: Enhances mitochondrial efficiency and fat oxidation.
Research areas
- Dual agonism at GIP and GLP-1 receptors, with a synergistic effect
- Weight loss of up to 22.5% reported in the SURMOUNT trials
- HbA1c reduction exceeding that of semaglutide in the SURPASS programme
- Cardiovascular markers and liver-fat measures
- Exploratory work in sleep apnoea and heart failure
Detailed Mechanism of Action
Tirzepatide is built on the native GIP backbone and engineered to engage the GLP-1 receptor as well. At the GIP receptor it binds with affinity comparable to native GIP; at the GLP-1 receptor it is roughly five-fold weaker than native GLP-1. This imbalance is deliberate, and it is a central reason researchers buy tirzepatide rather than a single-target incretin analog.
Once bound, both receptors couple to Gαs and raise intracellular cyclic AMP in pancreatic beta cells. The downstream effects documented in published models include glucose-dependent insulin secretion, suppression of glucagon release, slowed gastric emptying, and reduced food intake mediated through hypothalamic and hindbrain circuits.
At the GLP-1 receptor, tirzepatide shows biased signaling: it favors cAMP generation over β-arrestin recruitment, which limits receptor internalization and may sustain signaling over time. Willard and colleagues (2020) described this “imbalanced and biased” profile in detail, and it remains a popular topic for groups who buy tirzepatide for receptor pharmacology work.
The C20 fatty diacid moiety, attached through a hydrophilic linker at lysine 20, binds serum albumin and shields the peptide from renal clearance. Combined with the Aib residues at positions 2 and 13 that resist DPP-4 cleavage, this gives tirzepatide the extended half-life and once-weekly profile reported in the literature.
Published Research
Tirzepatide (originally LY3298176) was first characterized by Coskun and colleagues in 2018 in Molecular Metabolism, which documented its receptor affinities, five-day half-life, and early proof-of-concept data. Researchers who buy tirzepatide for in vitro work often use this paper as the reference standard for receptor-binding assays.
In the SURPASS-2 trial, Frías et al. (2021, NEJM) compared tirzepatide 5, 10, and 15 mg against semaglutide 1 mg over 40 weeks in 1,879 participants. HbA1c reductions of 2.01 to 2.30 percentage points and body-weight reductions of 7.6 to 11.2 kg exceeded semaglutide’s 1.86 points and 5.7 kg.
In SURMOUNT-1, Jastreboff et al. (2022, NEJM) reported mean weight reductions of 15.0%, 19.5%, and 20.9% at the 5, 10, and 15 mg doses over 72 weeks, versus 3.1% with placebo, in 2,539 adults with obesity. These datasets are the benchmark that laboratories cite when they buy tirzepatide to design comparative incretin studies.
Because this is a research compound, none of these clinical findings are claims about the product sold here. They explain why demand for the peptide is so high in 2026, and why a verified-purity source matters when you buy tirzepatide for your own protocols.
Why Choose Tirzepatide?
- Tirzepatide is one of the most advanced incretin-based peptides currently under research.
- Through its dual receptor activation, it offers a unique profile for optimized metabolic control and weight management.
- Its effects on glucose metabolism, fat oxidation, and energy balance make it a valuable tool in endocrine and metabolic research.
Order Tirzepatide and explore its potential in advanced metabolic and obesity research.
Published work examines how the two incretin-receptor pathways interact, along with the compound's sequence design, receptor selectivity, binding behaviour, and downstream metabolic signalling in controlled research. Batch-specific identity and measured content remain governed by the signed analytical record for each strength.
For laboratory purposes and personal observation only. Not for human consumption.
Research material handling
Transport and storage
Pre-mixed pen format
Peptide pens are supplied as a pre-mixed solution in a cartridge. No reconstitution is required.
Temperature-controlled transport
The supplied handling specification calls for insulated, temperature-controlled packaging. The approved transit range and permitted temperature excursions must be confirmed for the finished formulation.
Storage of reconstituted peptides
Peptide pens come pre-reconstituted and should be stored under refrigerated conditions whenever possible.
The following storage conditions are generally recommended:
- Room temperature (15–25 °C): Avoid prolonged storage
- Refrigerated (2–8 °C): Typically 4–8 weeks
Important: Most manufacturers recommend discarding reconstituted peptides within 4 weeks when stored at 2–8 °C. This recommendation is intentionally conservative and may not reflect the actual chemical stability of every peptide. In our own stability studies, many peptides reconstituted in bacteriostatic water showed no detectable degradation after 12 weeks of refrigerated storage. As peptide stability is highly sequence- and formulation-dependent, this result should not be extrapolated to all peptides without supporting stability data.
Analytical documentation
Tests
Latest published result
Liquilabs s.r.o.Signed Certificate of Analysis · 10mg
> 99.8%Purity by HPLC
- Batch number
- 2212212
- Tested
- 2026-06-22
Recorded QC panel
- AssayPeptide screening
- 8.98 mg
- PurityPeptide screening
- > 99.8%
- Identity (FTIR)FTIR spectrum
- 997
- Identity (RT)Retention time
- 0.999
- Bacterial EndotoxinUSP / Eur. Ph. 2.6.14
- < 0.001 EU/mg
These are the latest published results for this strength. The batch number is printed on each vial. Your supplied batch is confirmed against the matching published record when your order is allocated.
No certificate is available for this strength
We do not show a generic or mismatched document in its place.
Your batch is confirmed when your order is allocated.Latest published result
Liquilabs s.r.o.Signed Certificate of Analysis · 30mg
99.8%Purity by HPLC
- Batch number
- 3086853
- Tested
- 2026-08-06
Recorded QC panel
- AssayPeptide screening
- 31.5 mg
- PurityPeptide screening
- 99.8%
- Identity (FTIR)FTIR spectrum
- 996
- Identity (RT)Retention time
- 0.998
- Bacterial EndotoxinUSP / Eur. Ph. 2.6.14
- 0.007 EU/mg
- Molecular Ion MassMS deconvolution
- 4813 Da
These are the latest published results for this strength. The batch number is printed on each vial. Your supplied batch is confirmed against the matching published record when your order is allocated.
Source record
References
Coskun T, Sloop KW, Loghin C, et al. · 2018
LY3298176, a novel dual GIP and GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus: From discovery to clinical proof of concept
Discovery and receptor pharmacology of LY3298176.
Molecular Metabolism · 10.1016/j.molmet.2018.09.009 View source ↗National Center for Biotechnology Information
PubChem Compound Summary: Tirzepatide
Authoritative identity record for tirzepatide.
PubChem View source ↗Frías JP, Davies MJ, Rosenstock J, et al. · 2021
Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes
Primary clinical research report for the compound described as tirzepatide.
The New England Journal of Medicine · 10.1056/nejmoa2107519 View source ↗National Center for Biotechnology Information
PubChem compound record
PubChem View source ↗Customer reviews
Quality products,fast shipping,great refferal plan,only downside is that products in 4 mounths since my first order got more and more expensive ,but overall verry good experience.
Read full review →More than 2 weeks for package dispatch. They promised one free peptide next time. Sent me new tracking number but package still wasn't delivered to fedex. Last package (much much cheaper) was delivered in less than week. I will update if they will send my package. ok,package sent.
Read full review →Extremely satisfied with the product quality and overall experience. The customer service is polite and quick. All recommendations!
Read full review →Great service!
Read full review →Always on time and customer care is super great
Read full review →Fast good, and quality is perfect
Read full review →ordered 3 times now and everything ok every time.
Read full review →Trustworthy site with a huge catalog of products. Been purchasing from them for some time now never got disappointed. I could only recommend them.
Read full review →Great quality product
Read full review →Everything was great, super customer support, honest, reliable
Read full review →Everything ok. With little problem with package, but after contact with Customer Service everything went right. Good quality of products
Read full review →Excellent. Buying peptides online can be nerve wracking! But Adria are very transparent about all the checks and certifications. My experience with them was excellent. Great products at good prices and efficient P&P
Read full review →Quality products,fast shipping,great refferal plan,only downside is that products in 4 mounths since my first order got more and more expensive ,but overall verry good experience.
Read full review →More than 2 weeks for package dispatch. They promised one free peptide next time. Sent me new tracking number but package still wasn't delivered to fedex. Last package (much much cheaper) was delivered in less than week. I will update if they will send my package. ok,package sent.
Read full review →Extremely satisfied with the product quality and overall experience. The customer service is polite and quick. All recommendations!
Read full review →Great service!
Read full review →Always on time and customer care is super great
Read full review →Fast good, and quality is perfect
Read full review →ordered 3 times now and everything ok every time.
Read full review →Trustworthy site with a huge catalog of products. Been purchasing from them for some time now never got disappointed. I could only recommend them.
Read full review →Great quality product
Read full review →Everything was great, super customer support, honest, reliable
Read full review →Everything ok. With little problem with package, but after contact with Customer Service everything went right. Good quality of products
Read full review →Excellent. Buying peptides online can be nerve wracking! But Adria are very transparent about all the checks and certifications. My experience with them was excellent. Great products at good prices and efficient P&P
Read full review →Continue exploring



